ALEXANDROUPOLI, GREECE - 2026: The ThrombUS+ Horizon EU Project has officially initiated ThrombUS+ Clinical Study B1, to collect compression ultrasound videos using the newly developed ultrasound ThrombUS+ probe, specially designed to be integrated into a wearable for autonomous, point-of-care monitoring for deep vein thrombosis (DVT) of the lower limbs.
In parallel, the project has already successfully enrolled more than 1900 patients in 5 hospitals across Greece, Lithuania, Italy and France within the project’s Clinical Study A. The purpose is to collect large compression ultrasound datasets using conventional scanners to train, validate, and test Artificial Intelligence (AI) models to automatically detect deep vein thrombosis.
Further validation of the ThrombUS+ wearable will be carried out in clinical settings through one early feasibility study and one multi-center clinical trial.
ThrombUS+ stands at the forefront of a revolution in medical diagnostics and ultrasound imaging. The project paves the way towards the new era of disruptive diagnostics where artificial intelligence and ultraportable or even wearable technology promise to alleviate the burden on practitioners and transition diagnostics into continuous and autonomous point-of-care services.
